RecruitingNCT07148193

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Understanding Long-Term Sarcoma Survivorship: Risk Profiles, Outcomes and Unmet Needs - A Joint Project of Research, Sarcoma Centres and Patient Experts (PROSa+)

Sponsor

Technische Universität Dresden

Enrollment

1,600 participants

Start Date

Nov 28, 2025

Study Type

OBSERVATIONAL

Conditions

Quality of Life (QOL)Sarcoma Survivorship Medical Care

Summary

The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is gathering information about the quality of life and medical care of long-term sarcoma survivors in Germany — people who were diagnosed with sarcoma (a type of cancer affecting bones, muscles, or connective tissue) at least 5 years ago. **You may be eligible if...** - You are 18 years old or older - You were diagnosed with sarcoma (soft tissue sarcoma, bone sarcoma, or GIST) at least 5 years ago - You may or may not currently have active cancer **You may NOT be eligible if...** - Your diagnosis was a desmoid tumor (a different type of tumor) - You are unable to complete a structured questionnaire (for example, due to a language barrier, cognitive impairment, or dementia) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.